Holding in Company (9627A)
April 05 2012 - 11:23AM
UK Regulatory
TIDMUDG
RNS Number : 9627A
United Drug PLC
05 April 2012
Standard Form TR-1 Voting rights attached to shares- Article
12(1) of directive 2004/109/EC Financial instruments - Article
11(3) of the Commission Directive 2007/14/EC
This notification is for filing purposes only in accordance with
Regulation 22 of the Transparency (Directive 2004/109/EC)
Regulations 2007.
1. Identity of the issuer or the underlying issuer of existing
shares to which voting rights are attached: United Drug Plc
2. Reason for the notification (please tick the appropriate box or boxes):
[u] an acquisition or disposal of voting rights
[ ] an acquisition or disposal of financial instruments which
may result in the acquisition of shares already issued to which
voting rights are attached
[ ] an event changing the breakdown of voting rights
3. Full name of person(s) subject to the notification obligation: FMR LLC
4. Full name of shareholder(s) (if different from 3.): see schedule
5. Date of the transaction and date on which the threshold is
crossed or reached: 04 April 2012
6. Date on which issuer notified; 05 April 2012
7. Threshold(s) that is/are crossed or reached: 10%
8. Notified details:
A) Voting rights attached to shares
--------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of shares to the Triggering triggering transaction
(if possible transaction
using the
ISIN CODE)
----------------- ------------------------ -----------------------------------------------------
Number Number Number Number of voting % of voting
of Shares of Voting of shares rights rights
rights
----------------- ----------- ----------- ----------- -------------------- ------------------
Indirect Direct Indirect Direct Indirect
----------------- ----------- ----------- ----------- ------- ----------- ------- ---------
IE0033024807 23,869,406 23,869,406 24,161,606 24,161,606 10.11
----------------- ----------- ----------- ----------- ------- ----------- ------- ---------
SUBTOTAL
A (based
on aggregate
voting rights) 23,869,406 23,869,406 24,161,606 24,161,606 10.11
----------------- ----------- ----------- ----------- -------------------- ------------------
B) Financial Instruments
---------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------
Type of Expiration Exercise/Conversion Number of % of voting
financial Date Period/ voting rights rights
instrument Date that may
be acquired
if the instrument
is exercised/converted
------------ ----------- -------------------- ------------------------ ------------
SUBTOTAL
B (in relation
to all expiration
dates)
-------------------- ------------------------ ------------
Total (A+B) number of % of voting
voting rights rights
------------- --------------- ------------
24,161,606 10.11%
------------- --------------- ------------
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if
applicable: See attached schedule
10. In case of proxy voting: Number of voting rights proxy holder will acquire is 292,200
11. Additional information: None
This announcement has been issued through the Companies
Announcement Service of
The Irish Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISESSLFIIFESEFL
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Feb 2024 to Mar 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2023 to Mar 2024